Nello Mainolfi, Chief Executive Officer at Kymera Therapeutics, Inc. (KYMR), sold 46,018 shares at $52.53 ($2.4M) on 2021-06-10, disclosed to the SEC on 2021-06-11.
Open-market sale of $2.4M KYMR by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.63 | 10,103 | $512K | 21.6% |
| 2 | $50.63 | 10,103 | $512K | 21.6% |
| 3 | $51.46 | 6,912 | $356K | 15.0% |
| 4 | $51.46 | 6,912 | $356K | 15.0% |
| 5 | $52.53 | 5,994 | $315K | 13.3% |
| 6 | $52.53 | 5,994 |
| $315K |
| 13.3% |
| Total | $51.37 avg | 46,018 | $2.4M | 100% |
| Filing → |
| KYMR | SELL | 2026-07-02 | $9.2M | — | Filing → |
| KYMR | SELL | 2026-04-29 | $2.4M | — | Filing → |
| KYMR | SELL | 2026-02-25 | $2.7M | — | Filing → |